The references listed below have explicitly acknowledged use of reagents acquired from the NIH Tetramer Facility. References using tetramers from other sources are not included. If you are aware of references that we've missed, please let us know.

Nearly all references have been tagged with the tetramer reagents used in the reference. These tags can be found by clicking on the Abstract and Keywords link for each reference; the tags added by the Tetramer Facility are found at the bottom of the Keywords list. When you click on one of these tags, you will be presented with a list of all citations that have used that reagent.
Use Pubmed abbreviations, without punctuation
Date Format: 2021
comma-separated
L Bai, D Picard, B Anderson, V Chaudhary, A Luoma, B Jabri, EJ Adams, PB Savage, A Bendelac. (2012) " The majority of CD1d-sulfatide-specific T cells in human blood use a semiinvariant Vδ1 TCR. " Eur J Immunol 42. 2505-10 PMID: 22829134 DOI: 10.1002/eji.201242531 | Abstract and Keywords
Q Zhu, J Talton, G Zhang, T Cunningham, Z Wang, RC Waters, J Kirk, B Eppler, DM Klinman, Y Sui, S Gagnon, IM Belyakov, RJ Mumper, JA Berzofsky. (2012) " Large intestine-targeted, nanoparticle-releasing oral vaccine to control genitorectal viral infection. " Nat Med PMID: 22797811 DOI: 10.1038/nm.2866 | Abstract and Keywords
Z Liu, AN Courtney, LS Metelitsa, R Bittman. (2012) " C-Glycosphingolipids with an exo-methylene substituent: stereocontrolled synthesis and immunostimulation of mouse and human natural killer T lymphocytes. " Chembiochem 13. 1733-7 PMID: 22782839 DOI: 10.1002/cbic.201200374 | Abstract and Keywords
RA Langlois, A Varble, MA Chua, A García-Sastre, BR tenOever. (2012) " Hematopoietic-specific targeting of influenza A virus reveals replication requirements for induction of antiviral immune responses. " Proc Natl Acad Sci U S A 109. 12117-22 PMID: 22778433 DOI: 10.1073/pnas.1206039109 | Abstract and Keywords
S Rhost, L Löfbom, BM Rynmark, B Pei, JE Månsson, S Teneberg, M Blomqvist, SL Cardell. (2012) " Identification of novel glycolipid ligands activating a sulfatide-reactive, CD1d-restricted, type II natural killer T lymphocyte. " Eur J Immunol 42. 2851-60 PMID: 22777932 DOI: 10.1002/eji.201142350 | Abstract and Keywords
J Kwun, BC Oh, AC Gibby, R Ruhil, VT Lu, DW Kim, EK Page, OP Bulut, MQ Song, AB Farris, AD Kirk, SJ Knechtle, NN Iwakoshi. (2012) " Patterns of de novo allo B cells and antibody formation in chronic cardiac allograft rejection after alemtuzumab treatment. " Am J Transplant 12. 2641-51 PMID: 22759336 DOI: 10.1111/j.1600-6143.2012.04181.x | Abstract and Keywords
Y Zhou, B Callendret, D Xu, KM Brasky, Z Feng, LL Hensley, J Guedj, AS Perelson, SM Lemon, RE Lanford, CM Walker. (2012) " Dominance of the CD4(+) T helper cell response during acute resolving hepatitis A virus infection. " J Exp Med 209. 1481-92 PMID: 22753925 DOI: 10.1084/jem.20111906 | Abstract and Keywords
YY Lin, ME Jones-Mason, M Inoue, A Lasorella, A Iavarone, QJ Li, ML Shinohara, Y Zhuang. (2012) " Transcriptional regulator Id2 is required for the CD4 T cell immune response in the development of experimental autoimmune encephalomyelitis. " J Immunol 189. 1400-5 PMID: 22745378 DOI: 10.4049/jimmunol.1200491 | Abstract and Keywords